Functional Food & Beverages Segment Holds Maximum Share of Insoluble Dietary Fibers Market
The insoluble dietary fiber market is projected to grow at a CAGR of 9.2% from 2017 to 2022, to reach USD 2.66 billion by 2022. Factors such as growth in demand for functional foods, rising consumer awareness through government health programs, and increase in health-consciousness among consumers are driving this market.
Key Market Dynamics in Insoluble Dietary Fiber Market
Growth in demand for functional foods
Changes in lifestyles and lack of time have led to high consumption of functional foods in countries around the world, especially in Asia. With growth in workload, busy lifestyles, and increase in the number of working women (considering women play a predominant role in preparing meals in households), the time and means to intake healthy food have reduced. This has resulted in the growing demand for products that offer balanced nutrition. Thus, the consumer demand for functional foods, nutraceuticals, and supplements has been increasing. As insoluble dietary fibers form an essential ingredient in functional food products, their market is also increasing.
With changing consumer lifestyles, there is a need for intake of extra fiber. Insoluble dietary fiber content varies in different types of foods. Several key players such as Archer Daniels Midland Company (U.S.), Cargill (U.S.), and E. I. du Pont de Nemours and Company (U.S.), offer a range of insoluble dietary fibers obtained from different sources including wheat, oats, corn, peas, potato, legumes, and rice for their application in food, feed, and pharmaceutical products. Further, the products offered by these companies are also in accordance with consumer needs. This is projected to drive the market for insoluble dietary fibers.
The major restraining factor for the insoluble dietary fiber is time and investment required for the regulatory approval. The dietary fiber content has to be declared in the nutrition labeling, and health claims on the packaging of these contents are also strictly regulated. The procedures such as clinical trials are lengthy and require heavy investments, which may limit the number of new entrants in the market.
Comments
Post a Comment